The association and its member groups are “leading the way” in developing urology-specific measures that can be used for MIPS quality reporting, says LUGPA President Neal D. Shore, MD.
LUGPA Annual Meeting
Shorts
0:50
Expanding aquablation access in the ASC setting
3 days ago
by
Adam Mellis, MD, FACS
0:23
BCG-naïve NMIBC: Priorities for improving outcomes
5 days ago
by
Vignesh T. Packiam, MD
0:24
Why Dr. Spier wanted to lead LUGPA
8 days ago
by
Jeffrey M. Spier, MD
0:19
Phone agents and report automation: Starting AI in practice
9 days ago
by
Jared Olafsson, MS
0:20
Genomics over volume in intensifying prostate cancer therapy
9 days ago
by
Benjamin Garmezy, MD
0:44
From liver to kidney: The next questions for histotripsy
10 days ago
by
William C. Huang, MD
0:39
Making the most of networking at the LUGPA Annual Meeting
12 days ago
by
Benjamin H. Lowentritt, MD, FACS
0:35
Administrators, coordinators, and lab directors at LUGPA
16 days ago
by
Benjamin H. Lowentritt, MD, FACS
0:26
Dr. Lowentritt's LUGPA 2027 pick: Friday afternoon breakouts
20 days ago
by
Benjamin H. Lowentritt, MD, FACS
0:28
What policymakers must do to preserve patient choice
2 months ago
by
Celeste Kirschner, CAE, MHSA
Latest Content
Advertisement
Advertisement
Trending on Urology Times
1
Treatment interruptions in prostate cancer: Balancing PSA kinetics and quality of life
2
FDA approves durvalumab plus enfortumab vedotin for cisplatin-ineligible MIBC
3
American Cancer Society updates prostate cancer screening guidelines, recommends regular PSA testing
4
Q&A: Where ProACT fits in the male stress urinary incontinence algorithm
5